New 3D-Guided radiation boost aims to hit prostate tumors more precisely

NCT ID NCT05322356

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small study tests whether a 3D ultrasound system can help doctors place extra radioactive iodine seeds precisely into prostate tumors. Fifteen men with low- or intermediate-risk prostate cancer will receive the boost during standard brachytherapy. The main goal is to see if the seeds land in the right spot, not yet to measure cancer control or side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

iodine-125 radioactive implant

What this could lead to

If successful, this could improve precision in delivering radiation boosts to prostate tumors, potentially reducing side effects.

What could go wrong

This is a very small, early feasibility study with only 15 participants. It is not designed to prove effectiveness or safety, and the approach may not work as hoped.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Isabelle Boudry

    Grenoble, 38043, France